AstraZeneca
AZN
AZN
530 hedge funds and large institutions have $14B invested in AstraZeneca in 2018 Q2 according to their latest regulatory filings, with 60 funds opening new positions, 145 increasing their positions, 197 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.82% more ownership
Funds ownership: 31.35% → 32.17% (+0.82%)
26% less repeat investments, than reductions
Existing positions increased: 145 | Existing positions reduced: 197
29% less funds holding in top 10
Funds holding in top 10: 7 → 5 (-2)
Holders
530
Holding in Top 10
5
Calls
$164M
Puts
$57.1M
Top Buyers
| 1 | +$693M | |
| 2 | +$190M | |
| 3 | +$78.3M | |
| 4 |
Primecap Management
Pasadena,
California
|
+$52.9M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$52.2M |
Top Sellers
| 1 | -$345M | |
| 2 | -$69.1M | |
| 3 | -$63.1M | |
| 4 |
Goldman Sachs
New York
|
-$57.8M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$53.8M |